Introduction
Polymorphonuclear leukocytes (PMN) kill bacteria by 02-dependent and O2-independent mechanisms (1, 2) . Although substances contributing to both oxidative and nonoxidative modes of killing are released outside the phagocyte as well as A preliminary report of this work was presented at the annual meeting of the American Society for Clinical Investigation, Washington, DC, 4-7 May 1984, and was published in abstract form, 1984. Clin. Res. 32:A5 17. Received for publication 13 August 1984 and in revised form 15 February 1985.
into the phagocytic vacuole (3) , evidence of substantial extracellular killing of bacteria under normal circumstances is lacking. Hence, effective bacterial killing by PMN is generally presumed to require intracellular sequestration of bacteria (4) . We now provide evidence that human PMN do kill extracellular Escherichia coli (S15). concentration of 4 X 10' PMN/ml. Bacteria. E. coli S15, a K12 strain (Leu--Thr--Thi--Lac--Mal-), was kindly provided by Prof. S. Nojima, Faculty of Pharmaceutical Sciences, University of Tokyo.
Growth and labeling of bacteria. The bacteria were grown in a triethanolamine-buffered (pH 7.75-7.9) minimal salts medium (7) . Stationary-phase overnight cultures were transferred to fresh medium (diluted 1:10) supplemented with either L-amino acids mixture ['4C(uniform)], 0.5 gCi/ml; >250 Ci/mol; or [2- '4C]thymidine, 0.5 gCi/ml; 62 Ci/mol (New England Nuclear, Boston, MA) plus cold uridine (2 mM) to prelabeled bacterial proteins or DNA, respectively. After growth to midlogarithmic phase (2.54 h at 370C; 0.5-1 X 109 bacteria/ml, determined by measuring absorbance at 550 nm), the bacteria were harvested by centrifugation at 6,000 g for 10 min, resuspended in growth medium without radioactive precursors, and incubated for 30 min at 370C to chase residual precursors into macromolecules. The bacteria were then pelleted again and resuspended in sterile physiologic saline to 5 X 108/ml. Radiolabeled E. coli contained > 1,500 cpm/ I0O bacteria, >95% of which were precipitable in cold 5% trichloroacetic acid.
Sera. Sera collected from many normal human donors were pooled. fusion of unbound human serum protein against goat (anti-human C6) antibody (9) . Serum was collected from a New Zealand White rabbit before and after immunization with purified human bactericidal/permeabilityincreasing protein (BPI) (10) to provide preimmune and immune (anti-BPI) sera. To deplete immune sera of anti-BPI antibodies, antiserum was incubated with purified BPI (2 h at room temperature, then 24 h at 40C) and spun (10,000 g for 10 min) to remove immune complexes. Antibody titer was determined by double immunodiffusion of serum against BPI (9) . Anti-BPI serum produced a single-fused precipitin line against purified BPI and crude PMN extracts.
Incubation mixtures. Typical incubation mixtures contained 0.25 ml of HESS/20 mM Tris-HCI (pH 7.5)±PMN (10'), 0.05 ml of heattreated pooled human serum (or saline), and 0.20 ml of E. coil (108) in 10-ml siliconized Vacutainer tubes (no additive; Beckton, Dickinson & Co., Rutherford, NJ).
Incubation conditions: 02 depletion. Before mixing PMN and E. coli, individual samples containing PMN and serum and stock bacterial suspensions were equilibrated at room temperature in room air or under N2 to create aerobic or 02-depleted conditions. N2 (prepurified; Ohio Medical Products, Madison, WI) flushing was accomplished via 21-(inlet) and 18-(outlet) gauge needles inserted through the rubber stopper that seals these tubes. Flushing was carried out for 20-30 min (longer flushing, up to 60 min, did not alter the results). PMN suspensions were periodically shaken by hand to reduce cell clumping. The bacteria were added to tubes containing PMN via syringe. N2 flushing was continued for 5 min before removing the needles and sealing the tubes. Incubations were carried out in a rotating, (-100 rpm) waterbath at 370C and stopped by placing the tubes in ice and diluting the suspensions fourfold with ice-cold sterile saline containing sodium heparin (50 U/ml) to block further phagocytosis and killing (11) . The bacteria did not multiply during 60 min of incubation in the absence of PMN (100±4.3% and 95±2.5% of 0 min viability in the absence and presence of serum, respectively). N2-flushed PMN generated almost no respiratory burst (<3% of normal), measured either by hexose monophosphate shunt activity or by O°produc-tion (12) .
Measurement of uptake of E. coli by PMN. After cooling and dilution of the cell suspensions, I ml was transferred by syringe to a second N2-flushed tube for measurement of bacterial viability in whole cell suspensions (see below). 1 ml of 1.0 M sucrose was injected beneath the remaining I ml of cell suspension and free and PMNassociated E. coli were separated by centrifugation at 100 g for 10 min in a swinging bucket rotor. The PMN sedimented through the sucrose layer. The supernatant (-2 ml) was carefully removed (<100 41 remained) and the PMN pellet was resuspended in saline-heparin to the volume of the supernatant fraction. Bacterial radioactivity in the resuspended PMN pellet ("PMN associated") and in the supernatant fraction ("extracellular") were measured by conventional liquid scintillation counting procedures (11) . Supernatant E. coli were also enumerated by light microscopy using a Petroff-Hauser bacterial counting chamber. Bacterial uptake by PMN was measured as: (a) percentage of total recovered bacterial radioactivity present in the resuspended PMN pellet; and (b) percent reduction in the number of E. coil in the supernatant. The distribution of bacterial radioactivity was comparable using '4C-amino acid or ['4C]thymidine-labeled E.
coli and the supernatant radioactivity corresponded closely (±10%) to the number of E. coli enumerated under the microscope. Total recovery of bacterial radioactivity was 96±3.1%; 96±0.7% of E. coli were recovered in the supernatant fraction in the absence of PMN (n = 8).
To determine the properties of uningested bacteria and of the cellfree incubation mixture, cell suspensions were centrifuged at 100 g for 10 min.
Measurement of bacterial viability. To measure bacterial viability (i.e., colony-forming ability), samples were serially diluted in sterile saline and plated on nutrient agar. Samples of whole cell suspensions were taken both before and after sonication of the suspensions (40 W for 15 s at 0-40C; Sonifier Cell Disrupter, Heat Systems-Ultrasonics, Inc., Farmingdale, NY) to determine extracellular and total (extraand intracellular) bacterial viability, respectively. Sonication under the indicated conditions does not affect bacterial viability, but lyses PMN, releasing intracellular bacteria. The viability of PMN-associated and of extracellular E. coil was measured only after sonication. The number of colony-forming units on the plates was determined after incubation at 370C overnight.
Immunofluorescence. Samples (5-10 gl) of sonicated whole cell suspensions, resuspended PMN pellets and supernatants, and E. coli preincubated±BPI were dried on precleaned microscope slides and fixed (I min at 40C) in buffered formalin acetone (13) . The fixed smears were soaked for 15 min, in Dulbecco's phosphate-buffered saline (PBS), and rinsed with PBS supplemented with 0.2% bovine serum albumin (PBSA). Smears were overlaid for 10 min in a moist chamber at room temperature with 10% heat~treated pooled human serum, to occupy nonspecific binding sites, and rinsed with PBSA.
Next, smears were overlaid with either 0.5% rabbit anti-BPI, preimmune, or depleted serum for 30 min, washed three times for 30 min with PBS, rinsed with PBSA, and finally overlaid with 1% rhodaminelabeled swine (anti-rabbit Ig) Ig (Accurate Chemical & Scientific Corp., Westbury, NY) for 30 min. All sera were diluted in PBSA. Excess rhodamine-labeled Ig was removed in three washes (30 min) with PBS and the smears were covered with glycerol:PBS (9:1, vol/vol) and a coverslip and examined under oil using a Leitz Orthoplan fluorescent microscope (E. Leitz, Inc., Rockleigh, NY). Immunofluorescent staining of E. coli pretreated with purified BPI was not reduced either by sonication or by subsequent addition of heparin±heat-treated human serum. Heparin prevents attachment of unbound BPI to E. coli (14); E. coli exposed to BPI in the presence of heparin (50 U/ml) were not stained. Photographs were taken with Kodak Tri-X pan (ASA 400) film at approximately X 1,000 magnification. The micrographs shown in Fig. 2 were further enlarged 3-AX during photography.
Radioimmunoassay. E. coli preincubated±BPI or recovered in supernatants of PMN suspensions were sedimented by centrifugation at 10,000 g for 10 min to remove unbound protein. The bacteria were resuspended in isotonic saline containing 1% Triton X-100, 1% sodium deoxycholate and 1 mM phenylmethyl sulfonyl fluoride (2 X 108/ml), sonicated (as above), and incubated for 60 min at room temperature.
Aliquots (20 Evidence of Oindependent intracellular killing and O2 dependent extracellular killing. To assess more directly the location of live and dead E. coli after incubation with PMN, PMN-associated and extracellular radiolabeled E. coli were separated by low-speed centrifugation. Maximally, only about half of the added E. coli were recovered in the PMN pellet whether incubated in room air or under N2 (Fig. 1) ; this fraction was not increased by reducing the number of E. coli added per PMN (from 10 to 3) or by increasing the amount of serum added (up to 40%). Most uptake occurred within the first 5-15 min and PMN-associated bacteria were efficiently killed in room air as well as under N2 (Fig. 1) . After 5 min in room air, >50% of E. coli recovered in the PMN pellet were nonviable and nearly all were dead after 30 min. The rate and extent of killing of PMN-associated bacteria were only slightly less under N2 (Fig. 1) .
In contrast, the viability of the remaining extracellular E. coli differed greatly in room air and under N2 (Fig. 1) coccus aureus, a bacterial species that is not effectively killed by 02-independent bactericidal mechanisms (1, 12) . This indicates that omission of antibiotics for 60 h before blood was withdrawn from the patient eliminates the effect of the antibiotics on the bactericidal potential of the PMN in vitro (16) . Granule-associated BPI is bound to the surface of PMNassociated, but not of extracellular, E. coli. To verify that extracellular E. coli represent noningested rather than previously ingested and extruded bacteria, we examined the bacteria after incubation with PMN to determine whether BPI, a granuleassociated protein, had attached to E. coli. BPI, in crude PMN fractions as well as in purified form, has a high affinity for E. coli (12, 17) and rapidly binds to the bacterial surface (18 (Fig. 2 ). E. coli killed by either crude (granulerich) cell-free PMN fractions or by purified BPI show bright fluorescent staining after fixation and treatment with rabbit anti-BPI serum and rhodamine-labeled swine (anti-rabbit IgG) antibodies (Fig. 2, top left) . No bacterial staining was seen when BPI-killed E. coli were treated with preimmune serum (Fig. 2, bottom left panel) or immune serum depleted of anti-BPI antibodies, nor when either immune (Fig. 2, top right) , preimmune (Fig. 2, bottom right) or depleted antisera were used to treat E. coli that had not been exposed to BPI. Thus bacterial fluorescence is specifically due to the reaction of anti-BPI antibodies with BPI bound to E. coli.
E. coli recovered in the PMN pellet after aerobic or anaerobic incubation with intact PMN were also brightly fluorescent when treated with anti-BPI serum (Fig. 3, top + BPI center) but not when treated with preimmune serum (Fig. 3, bottom center). After 5 min of incubation, most PMN-associated bacteria were stained; after 15 min, essentially all E. coli were fluorescent. In contrast, no extracellular E. coli were stained at any time (up to 60 min) (Fig. 3, top right) nor was any bound BPI detectable on extracellular E. coli by radioimmunoassay (sensitivity limit: <3% of lethal BPI dose). Whole suspensions of E. coli and PMN sonicated without prior incubation also showed little or no bacterial fluorescence ( Fig.  3; top left) . Therefore, the fluorescence of PMN-associated E. coli reflects the rapid binding of BPI to E. coli, which occurred within the intact neutrophil and not during the disruption of PMN by sonication. Hence the absence of detectable BPI on extracellular E. coli confirms that these bacteria were not ingested at any time and, in room air, were killed extracellularly.
Effects of serum on uptake and killing by PMN. When viable extracellular E. coli, recovered from O2-depleted PMN suspensions, were incubated with a fresh population of PMN, roughly 50% of the bacteria were again ingested indicating that the noningested bacteria were not intrinsically resistant to phagocytosis. To determine whether limited ingestion was due to weak opsonizing activity of heat-treated serum, we prepared C6-depleted serum, which retains the opsonic but not the bactericidal activity of the heat-labile complement system (19) . Indeed, when heat-treated serum was replaced by C6-depleted serum, bacterial uptake by PMN increased to nearly 80% (Table III) . Again, nearly all PMN-associated E. coli were killed in O2-depleted as well as normally aerated cell suspensions. Consequently, overall bacterial killing under N2 was substantially greater when C6-depleted, rather than heat-treated, serum was used and was only slightly less than bacterial killing in room air (Table III) This study demonstrates substantial extracellular killing of E. coli by phagocytizing human PMN, using opsonindeficient heat-treated serum to permit only partial uptake of bacteria. Although ingested E. coli are killed more rapidly, nearly equal numbers of dead bacteria are located within and outside the PMN when killing is maximal. The gradual reduction in viability of extracellular E. coli could conceivably be explained by slow uptake of viable bacteria concomitant with extrusion of dead E. coli. However, two findings strongly argue against this possibility. First, the number and fraction of PMNassociated E. coli killed under room air and N2 is almost the same, yet appreciable numbers of dead extracellular bacteria are recovered only from aerobic cell suspensions. Second, the granule protein BPI rapidly attached to ingested E. coli but is not detected on extracellular bacteria. It thus appears that E. coli recovered in the extracellular medium were never exposed to the intravacuolar environment of the PMN and, hence, were killed outside the PMN during incubation in room air.
The defect in extracellular killing exhibited by both 02-depleted normal PMN and CGD leukocytes indicates that oxidative mechanisms play an essential role in extracellular killing of E. coli SI 5 by human PMN. Extracellular killing is not seen in the absence of serum, presumably because the oxidative metabolism of the PMN is not adequately stimulated under these conditions. Which, of the many potentially cytotoxic 02 metabolites generated during the respiratory burst, is (are) primarily responsible for extracellular killing of E. coli by the human PMN is still uncertain. Passo and Weiss (21) have shown that oxidative killing of extracellular E. coli by phorbol myristate acetate-stimulated PMN is mediated principally by the myeloperoxidase-H202-C-system, and we find, in preliminary experiments, that azide and cyanide, inhibitors of myeloperoxidase, reduce killing of E. coli by PMN in room air to roughly the same levels observed under N2. In both studies, the rate of extracellular killing is slow (relative to intracellular killing), possibly reflecting the action of longlived, slowly reactive oxidants such as hydrophilic N-chloramines that accumulate in the extracellular medium (21) (22) (23) (24) and can be bactericidal (22, 23) . However, in agreement with Passo and Weiss, we do not find evidence of bactericidal activity in the supernatant of suspensions of PMN and E. coli (tested toward freshly added E. colh) suggesting that slow killing may reflect relatively slow accumulation of short-lived oxidants on the bacterial surface (21) .
Although toxic 02 metabolites may also contribute to killing of PMN-associated E. coli, the virtually normal killing of these bacteria by 02-depleted normal PMN and by CGD leukocytes indicates that 02-independent mechanisms alone are sufficient to kill ingested E. coli. The slight increase in the number of viable E. coli recovered in the PMN pellet after incubation under N2 may be due at least in part to trapping of a small fraction (10%) of live extracellular bacteria. The fact that increased bacterial ingestion (replacing heat-treated serum with C6-depleted serum) results in a corresponding reduction in bacterial survival under N2 supports this view and underscores the effectiveness of 02-independent intracellular killing of this strain of E. coli. Oxygen-independent killing of several strains of E. coli, S. typhimurium, and certain other species of gram-negative bacteria by rabbit and human PMN has previously been shown (12, (25) (26) (27) . Both species of PMN possess multiple nonoxidative bactericidal systems (2, 28) . In both rabbit and human PMN, the principal°2-independent bactericidal agent toward these gram-negative bacteria appears to be BPI, judging from the potency of BPI (in cell-free PMN fractions) and the similarity of the lesions initially inflicted by isolated BPI and by intact PMN (10, 12, 29) . The demonstration in this study that BPI rapidly binds to ingested E. coli satisfies a primary requisite for its action in the intact neutrophil (17, 18) .
The absence of detectable BPI on noningested bacteria may explain the 02 dependence of extracellular killing of E. coli. This compartmentalization of 02-independent killing and the use of opsonin-deficient conditions have made this a particularly favorable setting for the demonstration of concomitant intra-and extracellular killing as well as of a previously unrecognized defect in extracellular killing by CGD leukocytes. Although heat-treated serum is a laboratory artifact, many situations occur in vivo in which (heat-labile) opsonins are deficient (19) . The ability of PMN to generate toxic 02 metabolites against extracellular microorganisms provides an effective ("back-up") bactericidal mechanism which may be important under conditions when intracellular sequestration of bacteria is incomplete.
